Current Opinion in Molecular Therapeutics | Most viewed articles in past 30 days

Log on / register
Feedback | Support | My details

home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central

Quick Search

	Current Opinion in Molecular Therapeutics
	BioMed Central
	PubMed Central
	PubMed

Jump to article


vol.	page no.

Current Opinion in Molecular Therapeutics

Home

Advanced search

Archive

Current Opinion journals

About this journal

Most viewed

Article alerts

Current Opinion in Molecular Therapeutics: Most viewed articles in past 30 days

[more info]

Figures given indicate the abstract, full text and PDF accesses on BioMed Central for each article, over the last 30 days. All research articles are also available via the PubMed Central archive, so the total number of accesses to each article is significantly higher. Lists of most-viewed articles in the past year and all time most-viewed articles are also available

most viewed articles over the last 30 days from all BioMed Central Journals

1. Accesses 34	Lentiviral vectors in clinical trials: Current status J D'Costa, SG Mansfield, LM Humeau Current Opinion in Molecular Therapeutics 2009, 11:554-564 (1October2009) [Abstract] [Full text] [PDF]
2. Accesses 29	Novel functions for small RNA molecules C Zhang Current Opinion in Molecular Therapeutics 2009, 11:641-651 (1December2009) [Abstract] [Full text] [PDF]
3. Accesses 29	Design and validation of siRNAs and shRNAs F Tilesi, P Fradiani, V Socci, D Willems, F Ascenzioni Current Opinion in Molecular Therapeutics 2009, 11:156-164 (26March2009) [Abstract] [Full text] [PDF] [PubMed] [Related articles]
4. Accesses 22	Pharmacogenomics of statin response LM Mangravite, RA Wilke, J Zhang, RM Krauss Current Opinion in Molecular Therapeutics 2008, 10:555-561 (27November2008) [Abstract] [Full text] [PDF] [PubMed] [Related articles]
5. Accesses 21	Induced pluripotent stem cells: Will they be safe? M Jalving, H Shepers Current Opinion in Molecular Therapeutics 2009, 11:383-393 (30July2009) [Abstract] [Full text] [PDF] [PubMed] [Related articles]
6. Accesses 21	Pharmacogenetics: Technologies to detect copy number variations D Dhawan, H Padh Current Opinion in Molecular Therapeutics 2009, 11:670-680 (1December2009) [Abstract] [Full text] [PDF]
7. Accesses 21	Combining radiation and immunotherapy for synergistic antitumor therapy TA Ferrara, JW Hodge, JL Gulley Current Opinion in Molecular Therapeutics 2009, 11:37-42 (23January2009) [Abstract] [Full text] [PDF] [PubMed] [Related articles]
8. Accesses 20	Reovirus: Rationale and clinical trial update R Lal, D Harris, S Postel-Vinay, J de Bono Current Opinion in Molecular Therapeutics 2009, 11:532-539 (1October2009) [Abstract] [Full text] [PDF]
9. Accesses 20	Membrane proteomics: The development of diagnostics based on protein shedding ZW Lai, DL Steer, AI Smith Current Opinion in Molecular Therapeutics 2009, 11:623-631 (1December2009) [Abstract] [Full text] [PDF]
10. Accesses 19	MicroRNA and stem cell regulation Y Wang, I Russell, C Chen Current Opinion in Molecular Therapeutics 2009, 11:292-298 (27May2009) [Abstract] [Full text] [PDF]

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us